{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T23:38:34Z","timestamp":1777765114934,"version":"3.51.4"},"reference-count":39,"publisher":"Polish Society of Microbiologists","issue":"1","license":[{"start":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T00:00:00Z","timestamp":1645920000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The infectious agents may be the etiological factor of up to 15\u201320% of cancers. In stomach cancer, attention is paid to\n                    <jats:italic>Helicobacter pylori<\/jats:italic>\n                    and Epstein-Barr virus, both of which cause gastritis and can lead to tumor development. In co-infection, the inflammatory process is much more intense. We assessed the seroprevalence towards\n                    <jats:italic>H. pylori<\/jats:italic>\n                    and EBV in 32 patients with diagnosed gastric cancer.\n                    <jats:italic>H. pylori<\/jats:italic>\n                    antibodies were found in 69% patients, and anti-EBV \u2013 in all of them. The study confirmed that co-infection of\n                    <jats:italic>H. pylori<\/jats:italic>\n                    and EBV seems to be important in etiopathology of gastric cancer.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:fig id=\"j_pjm-2022-004_fig_003\" position=\"anchor\" fig-type=\"figure\">\n                      <jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"graphic\/j_pjm-2022-004_fig_003.jpg\"\/>\n                    <\/jats:fig>\n                  <\/jats:p>","DOI":"10.33073\/pjm-2022-004","type":"journal-article","created":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T03:35:39Z","timestamp":1645932939000},"page":"123-129","source":"Crossref","is-referenced-by-count":5,"title":["<i>Helicobacter pylori<\/i>\n                    and Epstein-Barr Virus Co-Infection in Polish Patients with Gastric Cancer \u2013 A Pilot Study"],"prefix":"10.33073","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4044-6424","authenticated-orcid":false,"given":"Magdalena","family":"Dzikowiec","sequence":"first","affiliation":[{"name":"Department of Biomedicine and Genetics, Chair of Biology and Medical Microbiology , Medical University of Lodz , Lodz , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Przemys\u0142aw","family":"Lik","sequence":"additional","affiliation":[{"name":"2 Oncological Surgery Ward \u2013 Oncologic Surgery Clinic, Provincial Multispeciality Center of Oncology and Traumatology named after M. Kopernik in Lodz , Lodz , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Kisza\u0142kiewicz","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Genetics, Chair of Biology and Medical Microbiology , Medical University of Lodz , Lodz , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Kuczy\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Laboratory Medical Immunology, Chair of Biology and Medical Microbiology , Medical University of Lodz , Lodz , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Mordalski","sequence":"additional","affiliation":[{"name":"Central Clinical Hospital of the Medical University of Lodz , Lodz , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariusz","family":"Nejc","sequence":"additional","affiliation":[{"name":"2 Oncological Surgery Ward \u2013 Oncologic Surgery Clinic, Provincial Multispeciality Center of Oncology and Traumatology named after M. Kopernik in Lodz , Lodz , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz","family":"Piekarski","sequence":"additional","affiliation":[{"name":"2 Oncological Surgery Ward \u2013 Oncologic Surgery Clinic, Provincial Multispeciality Center of Oncology and Traumatology named after M. Kopernik in Lodz , Lodz , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Brzezia\u0144ska-Lasota","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Genetics, Chair of Biology and Medical Microbiology , Medical University of Lodz , Lodz , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Pastuszak-Lewandoska","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Laboratory Medical Immunology, Chair of Biology and Medical Microbiology , Medical University of Lodz , Lodz , Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18083","published-online":{"date-parts":[[2022,2,27]]},"reference":[{"key":"2026042905494634242_j_pjm-2022-004_ref_001","doi-asserted-by":"crossref","unstructured":"Biernat MM, Iwa\u0144czak B, Bi\u0144kowska A, Grabi\u0144ska J, Go\u015bciniak G. The prevalence of Helicobacter pylori infection in symptomatic children: a 13-year observational study in the Lower Silesian region. Adv Clin Exp Med. 2016 Mar\u2013Apr;25(2):303\u2013308. https:\/\/doi.org\/10.17219\/acem\/44372","DOI":"10.17219\/acem\/44372"},{"key":"2026042905494634242_j_pjm-2022-004_ref_002","doi-asserted-by":"crossref","unstructured":"Camargo MC, Kim WH, Chiaravalli AM, Kim KM, Corvalan AH, Matsuo K, Yu J, Sung JJY, Herrera-Goepfert R, Meneses-Gonzalez F, et al. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut. 2014 Feb; 63(2):236\u2013243. https:\/\/doi.org\/10.1136\/gutjnl-2013-304531","DOI":"10.1136\/gutjnl-2013-304531"},{"key":"2026042905494634242_j_pjm-2022-004_ref_003","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11; 513(7517):202\u2013209. https:\/\/doi.org\/10.1038\/nature13480","DOI":"10.1038\/nature13480"},{"key":"2026042905494634242_j_pjm-2022-004_ref_004","doi-asserted-by":"crossref","unstructured":"C\u00e1rdenas-Mondrag\u00f3n MG, Carre\u00f3n-Talavera R, Camorlinga-Ponce M, Gomez-Delgado A, Torres J, Fuentes-Panan\u00e1 EM. Epstein Barr virus and Helicobacter pylori co-infection are positively associated with severe gastritis in pediatric patients. PLoS One. 2013 Apr 24;8(4):e62850. https:\/\/doi.org\/10.1371\/journal.pone.0062850","DOI":"10.1371\/journal.pone.0062850"},{"key":"2026042905494634242_j_pjm-2022-004_ref_005","doi-asserted-by":"crossref","unstructured":"C\u00e1rdenas-Mondrag\u00f3n MG, Torres J, Flores-Luna L, Camorlinga-Ponce M, Carre\u00f3n-Talavera R, Gomez-Delgado A, Kasamatsu E, Fuentes-Panan\u00e1 EM. Case-control study of Epstein-Barr virus and Helicobacter pylori serology in Latin American patients with gastric disease. Br J Cancer. 2015 Jun 9;112(12):1866\u20131873. https:\/\/doi.org\/10.1038\/bjc.2015.175","DOI":"10.1038\/bjc.2015.175"},{"key":"2026042905494634242_j_pjm-2022-004_ref_006","doi-asserted-by":"crossref","unstructured":"Castaneda CA, Castillo M, Chavez I, Barreda F, Suarez N, Nieves J, Bernabe LA, Valdivia D, Ruiz E, Dias-Neto E, et al. Prevalence of Helicobacter pylori infection, its virulent genotypes, and Epstein-Barr virus in Peruvian patients with chronic gastritis and gastric cancer. J Glob Oncol. 2019 Sep;5:1\u20139. https:\/\/doi.org\/10.1200\/JGO.19.00122","DOI":"10.1200\/JGO.19.00122"},{"key":"2026042905494634242_j_pjm-2022-004_ref_007","unstructured":"Correa P. Human gastric carcinogenesis: a multistep and multifactorial process \u2013 First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992 Dec 15;52(24): 6735\u20136740."},{"key":"2026042905494634242_j_pjm-2022-004_ref_008","doi-asserted-by":"crossref","unstructured":"Czopek JP, Stojak M, Sinczak A, Popiela P, Kulig J, Rudzki Z, Stachura J. EBV-positive gastric carcinomas in Poland. Pol J Pathol. 2003;54(2):123\u2013128.","DOI":"10.1046\/j.1365-2036.16.s2.5.x"},{"key":"2026042905494634242_j_pjm-2022-004_ref_009","doi-asserted-by":"crossref","unstructured":"D\u00e1vila-Collado R, Jarqu\u00edn-Dur\u00e1n O, Dong LT, Espinoza JL. Epstein-Barr virus and Helicobacter pylori co-infection in non-malignant gastroduodenal disorders. Pathogens. 2020 Feb 6;9(2):104. https:\/\/doi.org\/10.3390\/pathogens9020104","DOI":"10.3390\/pathogens9020104"},{"key":"2026042905494634242_j_pjm-2022-004_ref_010","doi-asserted-by":"crossref","unstructured":"de Martel C, Georges D, Bray F, Ferlay J, Clifford G. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020 Feb;8(2):e180\u201390. https:\/\/doi.org\/10.1016\/S2214-109X(19)30488-7","DOI":"10.1016\/S2214-109X(19)30488-7"},{"key":"2026042905494634242_j_pjm-2022-004_ref_011","doi-asserted-by":"crossref","unstructured":"de Souza CRT, Almeida MCA, Khayat AS, da Silva EL, Soares PC, Chaves LC, Burbano RMR. Association between Helicobacter pylori, Epstein-Barr virus, human papillomavirus and gastric adenocarcinomas. World J Gastroenterol. 2018 Nov 21;24(43):4928\u20134938. https:\/\/doi.org\/10.3748\/wjg.v24.i43.4928","DOI":"10.3748\/wjg.v24.i43.4928"},{"key":"2026042905494634242_j_pjm-2022-004_ref_012","doi-asserted-by":"crossref","unstructured":"Fasciana T, Di Carlo P, Jouini A, Di Giulio M. Helicobacter pylori: infection and new perspective for the treatment. Can J Infect Dis Med Microbiol. 2019a Jul 29;2019:9431369. https:\/\/doi.org\/10.1155\/2019\/9431369","DOI":"10.1155\/2019\/9431369"},{"key":"2026042905494634242_j_pjm-2022-004_ref_013","doi-asserted-by":"crossref","unstructured":"Fasciana T, Serra N, Capra G, Mascarella C, Gagliardi C, Di Carlo P, Cannella S, Simonte MR, Lipari D, Sciortino M, et al. Helicobacter pylori and Epstein-Barr virus infection in gastric diseases: correlation with IL-10 and IL1RN polymorphism. J Oncol. 2019b Dec 6; 2019:1785132. https:\/\/doi.org\/10.1155\/2019\/1785132","DOI":"10.1155\/2019\/1785132"},{"key":"2026042905494634242_j_pjm-2022-004_ref_014","doi-asserted-by":"crossref","unstructured":"Fol M, Jachowicz E. [Infectious agents in carcinogenesis] (in Polish). Med Og Nauk Zdr. 2016;22(1):7\u201314. https:\/\/doi.org\/10.5604\/20834543.1198717","DOI":"10.5604\/20834543.1198717"},{"key":"2026042905494634242_j_pjm-2022-004_ref_015","doi-asserted-by":"crossref","unstructured":"Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY, et al. Global prevalence of Helicobacter pylori infection: Systematic review and meta-analysis. Gastroenterology. 2017 Aug;153(2): 420\u2013429. https:\/\/doi.org\/10.1053\/j.gastro.2017.04.022","DOI":"10.1053\/j.gastro.2017.04.022"},{"key":"2026042905494634242_j_pjm-2022-004_ref_016","doi-asserted-by":"crossref","unstructured":"Ieni A, Barresi V, Rigoli L, Fedele F, Tuccari G, Caruso RA. Morphological and cellular features of innate immune reaction in Helicobacter pylori gastritis: a brief review. Int J Mol Sci. 2016 Jan 15;17(1):109. https:\/\/doi.org\/10.3390\/ijms17010109","DOI":"10.3390\/ijms17010109"},{"key":"2026042905494634242_j_pjm-2022-004_ref_017","unstructured":"Iwanczak B, Laszewicz W, Iwanczak F, Dzierzanowska-Fangrat K, Rozynek M, Dzierzanowska D, Gosciniak G, Dlugosz J; Task force of the Polish Society of Gastroenterology. Genotypic and clinical differences of seropositive Helicobacter pylori children and adults in the Polish population. J Physiol Pharmacol. 2014 Dec;65(6):801\u2013807."},{"key":"2026042905494634242_j_pjm-2022-004_ref_018","doi-asserted-by":"crossref","unstructured":"Kobayashi Y, Kunogi T, Tanabe H, Murakami Y, Iwama T, Sasaki T, Takahashi K, Ando K, Nomura Y, Ueno N, et al. Gastric submucosa-invasive carcinoma associated with Epstein-Barr virus and endoscopic submucosal dissection: A case report. Gastrointest Oncol. 2019 Oct 15;11(10):925\u2013932. https:\/\/doi.org\/10.4251\/wjgo.v11.i10.925","DOI":"10.4251\/wjgo.v11.i10.925"},{"key":"2026042905494634242_j_pjm-2022-004_ref_019","doi-asserted-by":"crossref","unstructured":"Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020 Jun 4;21(11):4012. https:\/\/doi.org\/10.3390\/ijms21114012","DOI":"10.3390\/ijms21114012"},{"key":"2026042905494634242_j_pjm-2022-004_ref_020","unstructured":"Masrour-Roudsari J, Ebrahimpour S. Causal role of infectious agents in cancer: An overview. Caspian J Intern Med. 2017 Summer; 8(3):153\u2013158. https:\/\/doi.org\/10.22088\/cjim.8.3.153"},{"key":"2026042905494634242_j_pjm-2022-004_ref_021","doi-asserted-by":"crossref","unstructured":"Morales-Sanchez A, Fuentes-Panana EM. Epstein-Barr virus-associated gastric cancer and potential mechanisms of oncogenesis. Curr Cancer Drug Targets. 2017;17(6):534\u2013554. https:\/\/doi.org\/10.2174\/1568009616666160926124923","DOI":"10.2174\/1568009616666160926124923"},{"key":"2026042905494634242_j_pjm-2022-004_ref_022","doi-asserted-by":"crossref","unstructured":"Palrasu M, Zaika E, El-Rifai W, Que J, Zaika AI. Role of bacterial and viral pathogens in gastric carcinogenesis. Cancers (Basel). 2021 Apr 14;13(8):1878. https:\/\/doi.org\/10.3390\/cancers13081878","DOI":"10.3390\/cancers13081878"},{"key":"2026042905494634242_j_pjm-2022-004_ref_023","doi-asserted-by":"crossref","unstructured":"Polakovicova I, Jerez S, Wichmann IA, Sandoval-B\u00f3rquez A, Carrasco-V\u00e9liz N, Corval\u00e1n AH. Role of microRNAs and exosomes in Helicobacter pylori and Epstein-Barr virus associated gastric cancers. Front Microbiol. 2018 Apr 5;9:636. https:\/\/doi.org\/10.3389\/fmicb.2018.00636","DOI":"10.3389\/fmicb.2018.00636"},{"key":"2026042905494634242_j_pjm-2022-004_ref_024","doi-asserted-by":"crossref","unstructured":"Rihane FE, Hassou N, Nadifi S, Ennaji MM. Chapter 25 \u2013 Status of Helicobacter pylori coinfection with Epstein-Barr virus in gastric cancer. In: Ennaji MM, editor. Emerging and reemerging viral pathogens. Cambridge (USA): Academic Press; 2020. p. 571\u2013585. https:\/\/doi.org\/10.1016\/B978-0-12-819400-3.00025-9","DOI":"10.1016\/B978-0-12-819400-3.00025-9"},{"key":"#cr-split#-2026042905494634242_j_pjm-2022-004_ref_025.1","unstructured":"Rosen RD, Sapra A. TNM Classification [Internet, updated 2021 Feb 23]. Treasure Island (USA): StatPearls Publishing"},{"key":"#cr-split#-2026042905494634242_j_pjm-2022-004_ref_025.2","unstructured":"2021 [cited 2021 Sep 30]. Available from https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK553187\/"},{"key":"2026042905494634242_j_pjm-2022-004_ref_026","unstructured":"Santacroce L, Bufo P, Latorre V, Losacco T. [Role of mast cells in the physiopathology of gastric lesions caused by Helicobacter pylori] (in Italian). Chir Ital. 2000 Sep\u2013Oct;52(5):527\u2013531."},{"key":"2026042905494634242_j_pjm-2022-004_ref_027","unstructured":"Santacroce L, Cagiano R, Del Prete R, Bottalico L, Sabatini R, Carlaio RG, Prejbeanu R, Vermesan H, Dragulescu SI, Vermesan D, et al. Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight. Clin Ter. 2008 Nov\u2013Dec;159(6):457\u2013462."},{"key":"2026042905494634242_j_pjm-2022-004_ref_028","doi-asserted-by":"crossref","unstructured":"Sexton RE, Al Hallak MN, Diab M, Azmi AS. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020 Dec;39(4):1179\u20131203. https:\/\/doi.org\/10.1007\/s10555-020-09925-3","DOI":"10.1007\/s10555-020-09925-3"},{"key":"2026042905494634242_j_pjm-2022-004_ref_029","unstructured":"Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, Weiss LM. Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol. 1991 Sep;139(3):469\u2013474."},{"key":"2026042905494634242_j_pjm-2022-004_ref_030","doi-asserted-by":"crossref","unstructured":"Shinozaki-Ushiku A, Kunita A, Fukuyama M. Update on Epstein-Barr virus and gastric cancer (Review). Int J Oncol. 2015 Apr;46(4): 1421\u20131434. https:\/\/doi.org\/10.3892\/ijo.2015.2856","DOI":"10.3892\/ijo.2015.2856"},{"key":"2026042905494634242_j_pjm-2022-004_ref_031","doi-asserted-by":"crossref","unstructured":"Singh S, Jha HC. Status of Epstein-Barr virus coinfection with Helicobacter pylori in gastric cancer. J Oncol. 2017;2017:3456264. https:\/\/doi.org\/10.1155\/2017\/3456264","DOI":"10.1155\/2017\/3456264"},{"key":"2026042905494634242_j_pjm-2022-004_ref_032","doi-asserted-by":"crossref","unstructured":"Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018 Feb 7;10:239\u2013248. https:\/\/doi.org\/10.2147\/CMAR.S149619","DOI":"10.2147\/CMAR.S149619"},{"key":"2026042905494634242_j_pjm-2022-004_ref_033","doi-asserted-by":"crossref","unstructured":"Smatti MK, Al-Sadeq DW, Ali NH, Pintus G, Abou-Saleh H, Nasrallah GK. Epstein-Barr virus epidemiology, serology, and genetic variability of LMP-1 oncogene among healthy population: An update. Front Oncol. 2018 Jun 13;8:211. https:\/\/doi.org\/10.3389\/fonc.2018.00211","DOI":"10.3389\/fonc.2018.00211"},{"key":"2026042905494634242_j_pjm-2022-004_ref_034","doi-asserted-by":"crossref","unstructured":"Szaflarska-Pop\u0142awska A, Soroczy\u0144ska-Wrzyszcz A. Prevalence of Helicobacter pylori infection among junior high school students in Grudziadz, Poland. Helicobacter. 2019 Feb;24(1):e12552. https:\/\/doi.org\/10.1111\/hel.12552","DOI":"10.1111\/hel.12552"},{"key":"2026042905494634242_j_pjm-2022-004_ref_035","doi-asserted-by":"crossref","unstructured":"Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020 Mar;18(3):534\u2013542. https:\/\/doi.org\/10.1016\/j.cgh.2019.07.045","DOI":"10.1016\/j.cgh.2019.07.045"},{"key":"2026042905494634242_j_pjm-2022-004_ref_036","doi-asserted-by":"crossref","unstructured":"Violeta Filip P, Cuciureanu D, Sorina Diaconu L, Maria Vladareanu A, Silvia Pop C. MALT lymphoma: epidemiology, clinical diagnosis and treatment. J Med Life. 2018 Jul\u2013Sep;11(3):187\u2013193. https:\/\/doi.org\/10.25122\/jml-2018-0035","DOI":"10.25122\/jml-2018-0035"},{"key":"2026042905494634242_j_pjm-2022-004_ref_037","unstructured":"WHO. Cancer [Internet]. Geneva (Switzerland): World Health Organization; 2021 [cited 2021 Sep 30]. Available from https:\/\/www.who.int\/news-room\/fact-shwhoeets\/detail\/cancer"},{"key":"2026042905494634242_j_pjm-2022-004_ref_038","doi-asserted-by":"crossref","unstructured":"Yang J, Liu Z, Zeng B, Hu G, Gan R. Epstein-Barr virus-associated gastric cancer: A distinct subtype. Cancer Lett. 2020 Dec 28; 495: 191\u2013199. https:\/\/doi.org\/10.1016\/j.canlet.2020.09.019","DOI":"10.1016\/j.canlet.2020.09.019"}],"container-title":["Polish Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.33073\/pjm-2022-004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:17:02Z","timestamp":1777475822000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.33073\/pjm-2022-004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,27]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,2,27]]},"published-print":{"date-parts":[[2022,3,1]]}},"alternative-id":["10.33073\/pjm-2022-004"],"URL":"https:\/\/doi.org\/10.33073\/pjm-2022-004","relation":{},"ISSN":["2544-4646"],"issn-type":[{"value":"2544-4646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,27]]}}}